Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Malignant Neoplasm: early-phase trial registry
21 of 61 indexed Malignant Neoplasm trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #232 of 28,707 conditions by registered trial count.
61 US clinical trials · 21 currently recruiting · #232 of 28,707 conditions by registered trial count
Malignant Neoplasm: 61 US clinical trials tracked, 21 recruiting.
Malignant Neoplasm is the subject of 61 registered US clinical trials on ClinicalTrials.gov, 21 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 18 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 14 of these trials.
Enrollment posture brief
Registry condition malignant-neoplasm
OPEN 21 | RECR 34% | LATE 4 | EARLY 18 | RANK #232 | SPON 14
Volume-matched condition peers
Nearest open-share peer: Chronic Lymphocytic Leukemia (34% recruiting · 189 trials)
Malignant Neoplasm lists 21 open slots (34% of 61 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Malignant Neoplasm on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Malignant Neoplasm is recruiting below its size-band peers.
21 of 61 indexed trials (34.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Malignant Neoplasm research.
M.D. Anderson Cancer Center accounts for 14 of 61 trials (23%). 27 distinct sponsors appear on at least one study for this condition label.
-
Typical Malignant Neoplasm enrolment sits around 118 participants.
Median target enrolment is 118 among the 60 trials that report a genuine target (sentinel values excluded). 25 of those (41.7%) plan for fewer than 100 participants.
-
Malignant Neoplasm research is mostly interventional.
48 interventional and 13 observational studies make up this index (78.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
61 total, page 2 of 2
Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer
M.D. Anderson Cancer Center
NCT03040726
Meditative Slow Breathing or Isha Kriya Meditation in Improving Cancer-Related Symptoms in Hospitalized Participants With Cancer
M.D. Anderson Cancer Center
NCT03445572
Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment
Rutgers, The State University of New Jersey
NCT03228147
Psycho-Educational Program in Increasing Knowledge and Satisfaction and Decreasing Distress in Younger Patients With Cancer Receiving Treatment
City of Hope Medical Center
NCT01817335
A Computer-Based System for Symptom Reporting in Patients With Cancer Undergoing Treatment
Thomas Jefferson University
NCT03979846
Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain
M.D. Anderson Cancer Center
NCT04239976
Extended Use of Sodium Bicarbonate in Patients With Cancer
University of Arizona
NCT02531919
Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy
Wake Forest University Health Sciences
NCT01941810
Short-Term Fasting Before Chemotherapy in Treating Patients With Cancer
Mayo Clinic
NCT01175837
SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
University of Washington
NCT01982123
Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer
Mayo Clinic
NCT02598726
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 8 |
| Phase 3 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Malignant Neoplasm records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Malignant Neoplasm trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Malignant Neoplasm page
61 registered trials, 21 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 21 Malignant Neoplasm trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Malignant Neoplasm trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Malignant Neoplasm condition card totals 61 registered trials; most-linked intervention Questionnaire Administration; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.